Review Article

“Investigation of Self-Care Agency and Exercise Efficacy of Individuals Diagnosed with COPD during the COVID-19 Pandemic Process”

Volume: 3 Number: 3 September 30, 2022
EN

“Investigation of Self-Care Agency and Exercise Efficacy of Individuals Diagnosed with COPD during the COVID-19 Pandemic Process”

Abstract

Purpose: This study was conducted as a descriptive study to "Investigation of Self-Care Agency and Exercise Efficacy of Individuals Diagnosed with COPD during the COVID-19 Pandemic Process." Material and Methods:The study population consisted of individuals diagnosed with COPD in a city in the south of Turkey. The study sample consisted of individuals who voluntarily participated and met the inclusion criteria. No random sampling was used in the study. One hundred seven individuals who agreed to participate and met the study criteria constituted the study sample. The 'Sociodemographic Information Form,' the 'COPD Exercise Self-Regulatory Efficacy Scale (Ex-SRES), and Self-Care Agency Scale' was used for data collection. Number, percentage, mean, and descriptive statistics t-tests were used to analyze the data. Results: In the study results, it was found that there was a positive and significant relationship between self-care power and exercise efficacy in COPD patients. (p < 0.05). A significant difference was found between individuals diagnosed with COVID-19 and those who were not in terms of self-care agency and exercise efficacy. (p < 0.05). It was found that individuals with chronic disease had lower self-care agency and exercise efficacy than those without the disease. It was determined that the self-care agency and exercise efficacy of individuals diagnosed with COPD for more than ten years decreased. Conclusion: It was found that it is essential to monitor the self-care agency and exercise efficacy of COPD patients during COVID-19, and the self-care agency and exercise efficacy of patients decreased during this period. Keywords: COPD, Exercise Self-Regulatory Efficacy, Self-Care Agency, COVID-19

Keywords

References

  1. Andrianopoulos, V., Gloeckl, R., Schneeberger, T., Jarosch, I., Vogiatzis, I., Hume, E., ... & Kenn, K. (2021). Benefits of pulmonary rehabilitation in COPD patients with mild cognitive impairment–A pilot study. Respiratory Medicine, 185, 106478.
  2. Aytaç, S.O., Kiliç, S.P., Ovayolu, N. (2020). Effect of inhaler drug education on fatigue, dyspnea severity, and respiratory function tests in patients with COPD. Patient Educ Couns;103:709– 16.
  3. Davis, A. H., Figueredo, A. J., Fahy, B. F., Rawiworrakul, T. (2007). Reliability and validity of the Exercise Self-Regulatory Efficacy Scale for individuals with chronic obstructive pulmonary disease. Heart & lung : the journal of critical care, 36(3), 205–216. https://doi.org/10.1016/j.hrtlng.2006.08.007
  4. Di Marco, F., Santus, P., Sotgiu, G., Blasi, F., Centanni, S. (2015). Does improving exercise capacity and daily activity represent the holistic perspective of a new COPD approach? COPD. 12:575–81.
  5. Ebrahimi Belil, F., Alhani, F., Ebadi, A., Kazemnejad, A. (2018). Self-efficacy of people with chronic conditions: A qualitative directed content analysis. Journal of clinical medicine, 7(11), 411.
  6. Elbeddini, A., Tayefehchamani, Y. (2021). Amid COVID-19 pandemic: challenges with access to care for COPD patients. Research in Social and Administrative Pharmacy, 17(1), 1934-1937.
  7. Erol, O., Enc, N. (2011) Hypoglycemia fear and self-efficacy of turkish patients receiving insulin therapy. Asian Nurs Res 5(4):222–228
  8. Halbert, R.J., Natoli, J.L., (2006) Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: Systematic review and meta-analysis. Eur Respir J, 28: 523-32.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Review Article

Publication Date

September 30, 2022

Submission Date

April 7, 2022

Acceptance Date

July 27, 2022

Published in Issue

Year 2022 Volume: 3 Number: 3

APA
Ünal Aslan, K. S. (2022). “Investigation of Self-Care Agency and Exercise Efficacy of Individuals Diagnosed with COPD during the COVID-19 Pandemic Process”. Turkish Journal of Science and Health, 3(3), 198-206. https://doi.org/10.51972/tfsd.1099908
AMA
1.Ünal Aslan KS. “Investigation of Self-Care Agency and Exercise Efficacy of Individuals Diagnosed with COPD during the COVID-19 Pandemic Process.” TFSD. 2022;3(3):198-206. doi:10.51972/tfsd.1099908
Chicago
Ünal Aslan, Kevser Sevgi. 2022. “‘Investigation of Self-Care Agency and Exercise Efficacy of Individuals Diagnosed With COPD During the COVID-19 Pandemic Process’”. Turkish Journal of Science and Health 3 (3): 198-206. https://doi.org/10.51972/tfsd.1099908.
EndNote
Ünal Aslan KS (September 1, 2022) “Investigation of Self-Care Agency and Exercise Efficacy of Individuals Diagnosed with COPD during the COVID-19 Pandemic Process”. Turkish Journal of Science and Health 3 3 198–206.
IEEE
[1]K. S. Ünal Aslan, “‘Investigation of Self-Care Agency and Exercise Efficacy of Individuals Diagnosed with COPD during the COVID-19 Pandemic Process’”, TFSD, vol. 3, no. 3, pp. 198–206, Sept. 2022, doi: 10.51972/tfsd.1099908.
ISNAD
Ünal Aslan, Kevser Sevgi. “‘Investigation of Self-Care Agency and Exercise Efficacy of Individuals Diagnosed With COPD During the COVID-19 Pandemic Process’”. Turkish Journal of Science and Health 3/3 (September 1, 2022): 198-206. https://doi.org/10.51972/tfsd.1099908.
JAMA
1.Ünal Aslan KS. “Investigation of Self-Care Agency and Exercise Efficacy of Individuals Diagnosed with COPD during the COVID-19 Pandemic Process”. TFSD. 2022;3:198–206.
MLA
Ünal Aslan, Kevser Sevgi. “‘Investigation of Self-Care Agency and Exercise Efficacy of Individuals Diagnosed With COPD During the COVID-19 Pandemic Process’”. Turkish Journal of Science and Health, vol. 3, no. 3, Sept. 2022, pp. 198-06, doi:10.51972/tfsd.1099908.
Vancouver
1.Kevser Sevgi Ünal Aslan. “Investigation of Self-Care Agency and Exercise Efficacy of Individuals Diagnosed with COPD during the COVID-19 Pandemic Process”. TFSD. 2022 Sep. 1;3(3):198-206. doi:10.51972/tfsd.1099908


Turkish Journal of Science and Health (TFSD) 

E-mail:  tfsdjournal@gmail.com

Creative Commons Lisansı

Bu eser Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.

18106    18107    18238 18235 1839418234 1823618237    19024   18234   19690 19305215142164821682 21909  23284 30073

27460

     25763